iBio, Inc.IBIONYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank79
5Y CAGR+42.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+42.6%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
5.9x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 18.35% |
| 2024 | 48.13% |
| 2023 | 19.85% |
| 2022 | -28.12% |
| 2021 | -142.95% |
| 2020 | 3.11% |
| 2019 | -2.79% |
| 2018 | 1.34% |
| 2017 | -81.28% |
| 2016 | -64.78% |